The complaint alleges that PROCEPT BioRobotics misled shareholders between February 28, 2024, and February 25, 2026, by obscuring the true nature of its revenue growth. According to the filing, the company relied on an aggressive discount program that incentivized customers to stockpile handpieces far beyond actual procedure demand. This practice reportedly inflated reported sales figures by pulling future revenue into earlier quarters.

Legal representatives claim that by the end of the class period, this strategy resulted in an accumulation of more than 10,000 excess units in field inventory. The lawsuit contends that because management failed to disclose these operational risks, their public statements regarding the company's financial health lacked a reasonable basis. Investors seeking to participate in the action or discuss their legal standing may reach the Law Offices of Howard G. Smith at 215-638-4847 or via their website.